AI assistant
ABBOTT LABORATORIES — Director's Dealing 2006
Apr 4, 2006
29777_dirs_2006-04-04_e019253e-4376-4211-8fe5-e386dcb7c73b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2006-04-03
Reporting Person: Landgraf John C (Senior Vice President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2006-04-03 | Common shares without par value | S | 10000 | $42.41 | Disposed | 83675 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common shares without par value | 20000 | Indirect |
| Common shares without par value | 14851 | Indirect |
| Common shares without par value | 858 | Indirect |
Footnotes
F1: This sale was made pursuant to a previously adopted plan complying with rule 10b5-1(c). The plan was adopted on February 7, 2006.
F2: Held in the Anne Marie Landgraf Living Trust. The reporting person and his spouse are co-trustees of the trust. The trust is revocable by his spouse.
F3: Balance in the Abbott Laboratories Stock Retirement Trust as of March 31, 2006.
F4: Includes shares acquired under the Abbott Laboratories Dividend Reinvestment and Stock Purchase Plan in a transaction exempt from Section 16 under 16(a)-11.
F5: Reporting person disclaims beneficial ownership of all securities held by his son.